Can Monocytopenia be a New Indicator in Determining Survival in Covid-19 Disease?

被引:4
作者
Pehlivan, Ozlem [1 ]
Serin, Sibel O. [2 ]
Yesil, Ezgi E. [3 ]
Demirdag, Filiz [4 ]
机构
[1] Univ Hlth Sci, Umraniye Training & Res Hosp, Dept Rheumatol, Istanbul, Turkey
[2] Univ Hlth Sci, Umraniye Training & Res Hosp, Dept Internal Med, Istanbul, Turkey
[3] Univ Hlth Sci, Umraniye Training & Res Hosp, Dept Nephrol, Istanbul, Turkey
[4] Univ Hlth Sci, Umraniye Training & Res Hosp, Dept Geriatr, Istanbul, Turkey
关键词
Covid-19; survival; monocytopenia; CLINICAL CHARACTERISTICS; CORONAVIRUS DISEASE;
D O I
10.7754/Clin.Lab.2021.210215
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Monocytes play a central role in Covid-19 infection. Monocytopenia is especially observed in patients with severe infection. In our study, we aimed to investigate the effects of monocytopenia on survival in patients presenting with the suspicion of Covid-19. Methods: Patients diagnosed with Covid-19 who received inpatient or outpatient treatment in the pandemic clinic of Umraniye Training and Research Hospital between April 2020 and July 2020 were included in our retrospective cohort study. Patients were divided into two groups, severe and non-severe. Demographic data, laboratory parameters, those who were monocytopenic at presentation, those who developed monocytopenia during follow-up, and those with persistent monocytopenia were noted. Results: The study included 471 patients with a mean age of 50.4 +/- 18.2 years. Sixty-seven (14.2%) patients had severe and 404 (85.8%) had non-severe disease. The minimum value of monocytes detected during the follow-up in severe patients was significantly lower (p < 0.001). As patients were grouped into those with monocytopenia at the time of admission, those with monocytopenia developing during their follow-up, and those whose monocytopenia at admission persisted, they were compared with regards to the presence or absence of severe disease. Newly developing monocytopenia and persistent monocytopenia were significant in patients with severe disease (p < 0.001, p = 0,001 respectively). Also, among non-surviving patients, there was a significant difference in survival times in the monocytopenia group (p = 0.029). Conclusions: In our study, we found more developing and persistent monocytopenia in the severe group, and the survival time was low, especially in those with newly developing monocytopenia. The development of monocytopenia in the daily hemogram follow-up of the patients may increase the possibility of mortality, which suggests that monocytopenia may be a new marker in determining survival.
引用
收藏
页码:2339 / 2346
页数:8
相关论文
共 24 条
  • [11] Hematological findings in coronavirus disease 2019: indications of progression of disease
    Liu, Xiaoqing
    Zhang, Run
    He, Guangsheng
    [J]. ANNALS OF HEMATOLOGY, 2020, 99 (07) : 1421 - 1428
  • [12] Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
    Merad, Miriam
    Martin, Jerome C.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2020, 20 (06) : 355 - 362
  • [13] COVID-19: pathogenesis, genetic polymorphism, clinical features and laboratory findings
    Ozturk, Recep
    Tasova, Yesim
    Ayaz, Akif
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2020, 50 : 638 - 657
  • [14] Pourbagheri-Sigaroodi A, 2020, CLIN CHIM ACTA, V510, P475, DOI [10.1016/j.caa.2020.08.019, 10.1016/j.cca.2020.08.019]
  • [15] Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
    Qin, Chuan
    Zhou, Luoqi
    Hu, Ziwei
    Zhang, Shuoqi
    Yang, Sheng
    Tao, Yu
    Xie, Cuihong
    Ma, Ke
    Shang, Ke
    Wang, Wei
    Tian, Dai-Shi
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 71 (15) : 762 - 768
  • [16] Hematological findings and complications of COVID-19
    Terpos, Evangelos
    Ntanasis-Stathopoulos, Ioannis
    Elalamy, Ismail
    Kastritis, Efstathios
    Sergentanis, Theodoros N.
    Politou, Marianna
    Psaltopoulou, Theodora
    Gerotziafas, Grigoris
    Dimopoulos, Meletios A.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (07) : 834 - 847
  • [17] Turkish Ministry of Health, 2020, COVID 19 SCI COMM
  • [18] Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures
    Wang, Yixuan
    Wang, Yuyi
    Chen, Yan
    Qin, Qingsong
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (06) : 568 - 576
  • [19] Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
    Wu, Chaomin
    Chen, Xiaoyan
    Cai, Yanping
    Xia, Jia'an
    Zhou, Xing
    Xu, Sha
    Huang, Hanping
    Zhang, Li
    Zhou, Xia
    Du, Chunling
    Zhang, Yuye
    Song, Juan
    Wang, Sijiao
    Chao, Yencheng
    Yang, Zeyong
    Xu, Jie
    Zhou, Xin
    Chen, Dechang
    Xiong, Weining
    Xu, Lei
    Zhou, Feng
    Jiang, Jinjun
    Bai, Chunxue
    Zheng, Junhua
    Song, Yuanlin
    [J]. JAMA INTERNAL MEDICINE, 2020, 180 (07) : 934 - 943
  • [20] COVID-19: immunopathogenesis and Immunotherapeutics
    Yang, Li
    Liu, Shasha
    Liu, Jinyan
    Zhang, Zhixin
    Wan, Xiaochun
    Huang, Bo
    Chen, Youhai
    Zhang, Yi
    [J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)